Global Medical Footwear Market 2022-2028

SKU ID :TNV-12706635 | Published Date: 06-Aug-2018 | No. of pages: 125
PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market outline • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL • Segmentation by distribution channel • Comparison by distribution channel • Offline distribution channel – Market size and forecast 2017-2022 • Online distribution channel – Market size and forecast 2017-2022 • Market opportunity by distribution channel PART 09: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Men – Market size and forecast 2017-2022 • Women – Market size and forecast 2017-2022 • Market opportunity by end-user PART 10: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Key leading countries • Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Surge in innovative product designs • Eco-friendly medical footwear • Rise in product visibility and accessibility through online retailing PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Aetrex Worldwide • DJO Global • Drew Shoe • New Balance • OrthoFeet PART 16: APPENDIX • List of abbreviations Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition - Inclusions and exclusions checklist Exhibit 05: Market size 2017 Exhibit 06: Validation techniques employed for market sizing 2017 Exhibit 07: Global medical footwear market – Market size and forecast 2017-2022 ($ mn) Exhibit 08: Global medical footwear market – Year-over-year growth 2018-2022 (%) Exhibit 09: Five forces analysis 2017 Exhibit 10: Five forces analysis 2022 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2017 Exhibit 17: Customer landscape Exhibit 18: Distribution channel – Market share 2017-2022 (% share of revenue) Exhibit 19: Comparison by distribution channel Exhibit 20: Offline distribution channel – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Offline distribution channel – Year-over-year growth 2018-2022 (%) Exhibit 22: Online distribution channel – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Online distribution channel– Year-over-year growth 2018-2022 (%) Exhibit 24: Market opportunity by distribution channel Exhibit 25: End-user – Market share 2017-2022 (% share of revenue) Exhibit 26: Comparison by end-user Exhibit 27: Men – Market size and forecast 2017-2022 ($ mn) Exhibit 28: Men – Year-over-year growth 2018-2022 (%) Exhibit 29: Women – Market size and forecast 2017-2022 ($ mn) Exhibit 30: Women – Year-over-year growth 2018-2022 (%) Exhibit 31: Market opportunity by end-user Exhibit 32: Geography – Market share 2017-2022 (% share of revenue) Exhibit 33: Regional comparison Exhibit 34: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 35: Diabetes prevalence in Americas in 2017 Exhibit 36: Americas – Year-over-year growth 2018-2022 (%) Exhibit 37: Population aged 65 and above in US (total in millions) Exhibit 38: Population aged 65 and above in Canada (total in millions) Exhibit 39: Population aged 65 and above in Brazil (total in millions) Exhibit 40: Household final consumption expenditure in US 2012-2016 ($ trillions) Exhibit 41: Household final consumption expenditure in Canada 2012-2016 ($ trillions) Exhibit 42: Household final consumption expenditure in Brazil 2012-2016 ($ trillions) Exhibit 43: Top 3 countries in Americas Exhibit 44: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 45: Diabetes prevalence in EMEA in 2017 Exhibit 46: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 47: Population aged 65 and above in Germany (total in millions) Exhibit 48: Population aged 65 and above in UK (total in millions) Exhibit 49: Population aged 65 and above in France (total in millions) Exhibit 50: Household final consumption expenditure in Germany 2012-2016 ($ trillions) Exhibit 51: Household final consumption expenditure in UK 2012-2016 ($ trillions) Exhibit 52: Household final consumption expenditure in France 2012-2016 ($ trillions) Exhibit 53: Top 3 countries in EMEA Exhibit 54: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 55: Diabetes prevalence in APAC in 2017 Exhibit 56: APAC – Year-over-year growth 2018-2022 (%) Exhibit 57: Population aged 65 and above in China (total in millions) Exhibit 58: Population aged 65 and above in Japan (total in millions) Exhibit 59: Population aged 65 and above in South Korea (total in millions) Exhibit 60: Household final consumption expenditure in China 2012-2016 ($ trillions) Exhibit 61: Household final consumption expenditure in Japan 2012-2016 ($ trillions) Exhibit 62: Household final consumption expenditure in South Korea 2012-2016 ($ trillions) Exhibit 63: Top 3 countries in APAC Exhibit 64: Key leading countries Exhibit 65: Market opportunity Exhibit 66: Life expectancy 2010-2014 – World and regions (years) Exhibit 67: Healthy life expectancy (years) and years lived with disability or disease burden 2010-2016 – World Exhibit 68: Median age (of overall population) 2010-2015 – World (years) Exhibit 69: Population aged 65 and above, total in EU and US 2010-2017 (millions) Exhibit 70: Global population ages 65 and above, total 2010-2017 (millions) Exhibit 71: Global population ages 65 and above 2010-2017 (% of total) Exhibit 72: Individuals using the Internet – Worldwide 2011-2016 (% of total population) Exhibit 73: Global mobile cellular subscriptions 2011-2016 (per 100 people) Exhibit 74: Vendor landscape Exhibit 75: Landscape disruption Exhibit 76: Vendors covered Exhibit 77: Vendor classification Exhibit 78: Market positioning of vendors Exhibit 79: Aetrex Worldwide – Vendor overview Exhibit 80: Aetrex Worldwide – Business segments Exhibit 81: Aetrex Worldwide – Organizational developments Exhibit 82: Aetrex Worldwide – Key offerings Exhibit 83: DJO Global – Vendor overview Exhibit 84: DJO Global – Business portfolio Exhibit 85: DJO Global – Organizational developments Exhibit 86: DJO Global – Key offerings Exhibit 87: Drew Shoe – Vendor overview Exhibit 88: Drew Shoe – Business segments Exhibit 89: Drew Shoe – Organizational developments Exhibit 90: Drew Shoe – Key offerings Exhibit 91: New Balance – Vendor overview Exhibit 92: New Balance – Business segments Exhibit 93: New Balance – Organizational developments Exhibit 94: New Balance – Key offerings Exhibit 95: OrthoFeet – Vendor overview Exhibit 96: OrthoFeet – Business segments Exhibit 97: OrthoFeet – Organizational developments Exhibit 98: OrthoFeet – Key offerings
Aetrex Worldwide DJO Global Drew Shoe New Balance OrthoFeet
  • PRICE
  • $2500
    $4000

Our Clients